Core Scientific (NASDAQ:CORZ) Stock Rating Upgraded by Wall Street Zen

Posted by Brenda Bartman on Nov 7th, 2026

Core Scientific (NASDAQ:CORZ – Get Free Report) was upgraded by analysts at Wall Street Zen from a “sell” rating to a “hold” rating in a research report issued on Saturday, Wall Street Zen reports.

Several other research analysts have also commented on CORZ. Compass Point reissued a “buy” rating and issued a $36.00 price objective on shares of Core Scientific in a research note on Wednesday, July 29th. BTIG Research reaffirmed a “buy” rating and issued a $38.00 price objective on shares of Core Scientific in a report on Thursday, October 15th. Rothschild & Co Redburn started coverage on shares of Core Scientific in a report on Monday, September 21st. They issued a “neutral” rating and a $16.00 target price on the stock. Wolfe Research reaffirmed a “buy” rating on shares of Core Scientific in a research note on Wednesday, July 29th. Finally, Freedom Capital raised Core Scientific from a “hold” rating to a “strong-buy” rating in a report on Thursday, July 30th. Two analysts have rated the stock with a Strong Buy rating, seventeen have issued a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $30.54.

Read Our Latest Report on Core Scientific

Core Scientific Stock Performance

Shares of CORZ opened at $11.76 on Friday. Core Scientific has a one year low of $10.59 and a one year high of $30.46. The company has a 50-day simple moving average of $15.68 and a two-hundred day simple moving average of $19.48.

Core Scientific (NASDAQ:CORZ – Get Free Report) last posted its quarterly earnings results on Thursday, November 5th. The company reported $0.47 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.07) by $0.54. The company had revenue of $232.87 million for the quarter, compared to analyst estimates of $196.54 million. As a group, equities research analysts predict that Core Scientific will post -1.36 EPS for the current year.

Insider Buying and Selling at Core Scientific

In related news, insider Todd DuChene sold 10,000 shares of the company’s stock in a transaction that occurred on Monday, October 19th. The shares were sold at an average price of $13.87, for a total transaction of $138,700.00. Following the completion of the transaction, the insider directly owned 1,143,286 shares in the company, valued at $15,857,376.82. This represents a 0.87% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Over the last ninety days, insiders bought 19,000 shares of company stock worth $342,290 and sold 100,000 shares worth $1,628,600. 1.70% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On Core Scientific

Large investors have recently bought and sold shares of the stock. Parallel Advisors LLC raised its stake in Core Scientific by 125.0% during the third quarter. Parallel Advisors LLC now owns 1,800 shares of the company’s stock worth $29,000 after acquiring an additional 1,000 shares during the period. Covestor Ltd lifted its holdings in Core Scientific by 75.3% during the third quarter. Covestor Ltd now owns 116,647 shares of the company’s stock valued at $1,864,000 after purchasing an additional 50,100 shares during the last quarter. Mirae Asset Global Investments Co. Ltd. purchased a new stake in shares of Core Scientific in the 3rd quarter worth about $42,000. Partners Wealth Management LLC bought a new stake in Core Scientific during the 3rd quarter valued at approximately $317,000. Finally, CUSHING ASSET MANAGEMENT LP dba NXG INVESTMENT MANAGEMENT lifted its position in shares of Core Scientific by 5,468.6% in the 3rd quarter. CUSHING ASSET MANAGEMENT LP dba NXG INVESTMENT MANAGEMENT now owns 389,800 shares of the company’s stock worth $6,229,000 after purchasing an additional 382,800 shares during the period.

Core Scientific News Summary

Here are the key news stories impacting Core Scientific this week:

Positive Sentiment: Core Scientific reported Q3 2026 earnings of $0.47 per share, versus analysts’ expected loss, while revenue of $232.87 million also exceeded estimates. The results provide a fundamental catalyst for investor optimism. Core Scientific surpasses Q3 earnings and revenue estimates
Positive Sentiment: Traders bought 143,273 CORZ call options Friday, about 127% above average volume. The surge may reflect increased bullish speculation, though options activity does not guarantee future gains.
Neutral Sentiment: Needham cut its price target from $35 to $28 but maintained a Buy rating. The lower target tempers the outlook, while the continued Buy rating signals the analyst still sees substantial potential upside relative to the cited $11.76 price.
Negative Sentiment: Insider Todd Duchene sold 10,000 shares for $127,800, reducing his holdings by 0.88%. The sale is a modest cautionary signal, although he retained more than 1.1 million shares. Core Scientific insider sale

Core Scientific Company Profile

(Get Free Report)

Core Scientific, Inc is a digital infrastructure company that develops and operates data centers for high-performance computing. The company has historically focused on bitcoin mining, using specialized computing equipment and supporting infrastructure to validate transactions on the Bitcoin network. It also provides hosting and infrastructure services for other digital asset miners.

Core Scientific is expanding its business toward hosting high-performance computing and artificial intelligence workloads.